Cargando…
iPSC Therapy for Myocardial Infarction in Large Animal Models: Land of Hope and Dreams
Myocardial infarction is the main driver of heart failure due to ischemia and subsequent cell death, and cell-based strategies have emerged as promising therapeutic methods to replace dead tissue in cardiovascular diseases. Research in this field has been dramatically advanced by the development of...
Autores principales: | Martínez-Falguera, Daina, Iborra-Egea, Oriol, Gálvez-Montón, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698445/ https://www.ncbi.nlm.nih.gov/pubmed/34944652 http://dx.doi.org/10.3390/biomedicines9121836 |
Ejemplares similares
-
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis
por: Aimo, Alberto, et al.
Publicado: (2022) -
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers
por: Iborra-Egea, Oriol, et al.
Publicado: (2022) -
A Cell-Enriched Engineered Myocardial Graft Limits Infarct Size and Improves Cardiac Function: Pre-Clinical Study in the Porcine Myocardial Infarction Model
por: Perea-Gil, Isaac, et al.
Publicado: (2016) -
Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction
por: Rojas, Sebastian V., et al.
Publicado: (2017) -
Deep Learning Analyses to Delineate the Molecular Remodeling Process after Myocardial Infarction
por: Iborra-Egea, Oriol, et al.
Publicado: (2021)